Laboratory Corp American Holdings (LH)
260.32
-7.37 (-2.75%)
NYSE · Last Trade: Jul 25th, 12:13 PM EDT
Via Benzinga · July 25, 2025
Via Benzinga · July 25, 2025
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 9.5% year on year to $3.53 billion. Its non-GAAP profit of $4.35 per share was 4.5% above analysts’ consensus estimates.
Via StockStory · July 25, 2025
Labcorp Raises Full Year Guidance After Q2 Earnings Beat Wall Street Expectations: Retail Sees Rally To $330stocktwits.com
Via Stocktwits · July 24, 2025
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · July 24, 2025
Shares of healthcare diagnostics company Labcorp Holdings (NYSE:LH)
jumped 6.8% in the afternoon session after the company reported second-quarter earnings that beat analyst expectations and raised its full-year financial outlook. The laboratory network operator posted an adjusted EPS of $4.35, which surpassed consensus estimates. Revenue for the quarter increased 9.5% year-over-year to $3.53 billion, driven by growth in both its Diagnostics and Biopharma segments. In a significant show of confidence, Labcorp boosted its full-year 2025 guidance, projecting adjusted earnings per share between $16.05 and $16.50 and revenue growth between 7.5% and 8.6%. The company also noted that it had repurchased $200 million of its common stock during the quarter, further underscoring the strength of its financial position and business performance.
Via StockStory · July 24, 2025
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via Chartmill · July 24, 2025
Labcorp beat Q2 earnings and revenue estimates and raised full-year guidance, supported by margin expansion and continued acquisition activity.
Via Benzinga · July 24, 2025
Via Benzinga · July 24, 2025
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Thursday. Discover the gap up and gap down stocks in the S&P500 index.
Via Chartmill · July 24, 2025
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) announced better-than-expected revenue in Q2 CY2025, with sales up 9.5% year on year to $3.53 billion. Its non-GAAP profit of $4.35 per share was 4.5% above analysts’ consensus estimates.
Via StockStory · July 24, 2025
Labcorp (LH) reported mixed Q2 2025 earnings, missing revenue estimates but beating EPS. Shares rose as raised full-year guidance offset concerns.
Via Chartmill · July 24, 2025
Healthcare diagnostics company Labcorp Holdings (NYSE:LH)
will be reporting earnings this Thursday morning. Here’s what to expect.
Via StockStory · July 22, 2025
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices.
But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Via StockStory · July 21, 2025
With markets typically weakening in August and September, now is a strategic time to consider bearish trades like Labcorp Holdings.
Via Benzinga · July 17, 2025
Looking back on testing & diagnostics services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Labcorp (NYSE:LH) and its peers.
Via StockStory · July 10, 2025
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Via StockStory · July 7, 2025
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning.
Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Via StockStory · July 4, 2025